Table of Content

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. CORONARY GUIDEWIRES ARE THE MAJORLY USED APPLICATION
3.2.2. HYDROPHOBIC COATING IS THE FASTEST GROWING COATED TYPE
3.2.3. HOSPITALS ARE THE HIGHEST REVENUE GENERATING END USERS

4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. RISE IN PREVALENCE OF CHRONIC DISEASES
4.2.2. INCREASING DEMAND FOR MI PROCEDURES
4.2.3. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONS
4.2.4. PREVAILING HIGH UNMET MEDICAL NEEDS
4.3. MARKET RESTRAINTS
4.3.1. RISKS ASSOCIATED WITH THE USE OF GUIDEWIRES
4.3.2. UNFAVORABLE PREFERENCE FOR DRUGS
4.3.3. ISSUE IN LOST GUIDEWIRE RETRIEVAL
4.4. MARKET OPPORTUNITIES
4.4.1. TECHNOLOGICAL ADVANCEMENTS
4.4.2. SURGE IN THE ADOPTION OF VASCULAR PROCEDURES
4.5. MARKET CHALLENGES
4.5.1. COMPLEXITIES ASSOCIATED IN THE MANUFACTURING OF VASCULAR GUIDEWIRES
4.5.2. PRICING COUPLED WITH PAUCITY OF PRODUCT DIFFERENTIATION

5. MARKET BY APPLICATION
5.1. CORONARY GUIDEWIRES
5.2. PERIPHERAL GUIDEWIRES
5.3. UROLOGICAL GUIDEWIRES
5.4. NEUROVASCULAR GUIDEWIRES

6. MARKET BY COATING TYPE
6.1. COATED
6.2. NON-COATED

7. MARKET BY END USER
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS

8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCES MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS
8.1.3. BARGAINING POWER OF BUYER
8.1.4. BARGAINING POWER OF SUPPLIER
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. VALUE CHAIN ANALYSIS
8.3. REGULATORY FRAMEWORK
8.4. SUPPLY CHAIN ANALYSIS
8.5. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS
9.1. ASIA PACIFIC
9.1.1. JAPAN
9.1.2. CHINA
9.1.3. INDIA
9.1.4. AUSTRALIA
9.1.5. SOUTH KOREA
9.1.6. REST OF APAC

10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. COMPANY PROFILES
10.2.1. ABBOTT
10.2.2. B BRAUN MELSUNGEN AG
10.2.3. BECTON DICKINSON AND COMPANY
10.2.4. BIOTRONIK SE & CO. KG
10.2.5. BOSTON SCIENTIFIC CORPORATION
10.2.6. CARDINAL HEALTH INC.
10.2.7. COOK MEDICAL LLC
10.2.8. EDWARD LIFESCIENCES
10.2.9. GALTNEEDLETECH
10.2.10. KONINKLIJKE PHILIPS N.V.
10.2.11. MEDTRONIC
10.2.12. MERIT MEDICAL SYSTEMS
10.2.13. OLYMPUS CORPORATION
10.2.14. TERUMO

List of Tables
TABLE 1 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 2 MAJOR COMPLICATIONS CAUSED BY GUIDEWIRES DURING ENDOVASCULAR OR STENTING PROCEDURES
TABLE 3 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC CORONARY GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC PERIPHERAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC UROLOGICAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC NEUROVASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC COATED MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC NON-COATED MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC AMBULATORY SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 14 JAPAN VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 JAPAN VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 16 JAPAN VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 17 CHINA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 18 CHINA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 19 CHINA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 20 INDIA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 21 INDIA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 22 INDIA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 23 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 24 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 25 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 26 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 27 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 28 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)

List of Figures
FIGURE 1 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY CORONARY GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY PERIPHERAL GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY UROLOGICAL GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY NEUROVASCULAR GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY COATING TYPE 2018 & 2027 (%)
FIGURE 8 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY COATED 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY NON-COATED 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY END USER 2018 & 2027 (%)
FIGURE 11 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
FIGURE 13 PORTER’S FIVE FORCE MODEL
FIGURE 14 JAPAN VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 15 POPULATION ABOVE 65 YEARS IN JAPAN 2015 & 2050 (%)
FIGURE 16 CHINA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 17 INDIA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 18 POPULATION ABOVE 60 YEARS OF AGE 2015 & 2050 (%)
FIGURE 19 AUSTRALIA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 20 SOUTH KOREA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 21 REST OF APAC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 22 VASCULAR GUIDEWIRES COMPANY SHARE ANALYSIS 2018 (%)



List of Figures


List of Figures


FIGURE 1 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 3 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY CORONARY GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY PERIPHERAL GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY UROLOGICAL GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY NEUROVASCULAR GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY COATING TYPE 2018 & 2027 (%)
FIGURE 8 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY COATED 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY NON-COATED 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY END USER 2018 & 2027 (%)
FIGURE 11 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
FIGURE 13 PORTER’S FIVE FORCE MODEL
FIGURE 14 JAPAN VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 15 POPULATION ABOVE 65 YEARS IN JAPAN 2015 & 2050 (%)
FIGURE 16 CHINA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 17 INDIA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 18 POPULATION ABOVE 60 YEARS OF AGE 2015 & 2050 (%)
FIGURE 19 AUSTRALIA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 20 SOUTH KOREA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 21 REST OF APAC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 22 VASCULAR GUIDEWIRES COMPANY SHARE ANALYSIS 2018 (%)

 

List of Tables


List of Tables


TABLE 1 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 2 MAJOR COMPLICATIONS CAUSED BY GUIDEWIRES DURING ENDOVASCULAR OR STENTING PROCEDURES
TABLE 3 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC CORONARY GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC PERIPHERAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC UROLOGICAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC NEUROVASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC COATED MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC NON-COATED MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC AMBULATORY SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 14 JAPAN VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 JAPAN VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 16 JAPAN VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 17 CHINA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 18 CHINA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 19 CHINA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 20 INDIA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 21 INDIA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 22 INDIA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 23 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 24 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 25 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 26 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 27 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 28 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)